Stryker & Wright Medical v. OsteoMed — Federal Circuit Splits Decision on Bone Plate Patent
Stryker Corporation and Wright Medical Technology challenged OsteoMed’s US8529608B2 patent covering a bone plate with a transfixation screw hole in a 865-day Federal Circuit appeal. The court issued a mixed ruling — affirming in part, vacating and remanding in part, and reversing in part — leaving portions of the patent’s validity unresolved.
Federal Circuit splits the difference on OsteoMed bone plate patent validity
Stryker Corporation and Wright Medical Technology, Inc. brought an appeal before the U.S. Court of Appeals for the Federal Circuit (Case No. 23-1925) challenging the patentability of OsteoMed, LLC’s US8529608B2, which protects a bone plate with a transfixation screw hole — a component used in orthopaedic surgical fixation. The appeal was filed on May 22, 2023 and resolved on October 3, 2025, spanning 865 days at the appellate level.
The Federal Circuit delivered a fragmented disposition: it affirmed certain aspects of the lower tribunal’s findings, vacated and remanded others for further proceedings, and reversed specific determinations outright. The appeal was also dismissed in part, meaning some issues never received a merits ruling. This three-way outcome suggests the court found both merit and error in the underlying patentability analysis, leaving the full scope of US8529608B2’s validity subject to continued adjudication on remand.
An 865-day appellate timeline is consistent with a technically complex patentability dispute involving multiple contested claims. The mixed ruling is notable because it neither fully vindicates OsteoMed’s patent nor grants appellants a clean invalidation victory — a commercially significant ambiguity for competitors in the orthopaedic fixation device market. What the remanded issues will yield on return to the lower tribunal remains an open question from the public record.
Filing to Appeal Dismissed in Part in 865 days
865 days from filing to Federal Circuit decision — a substantial appellate timeline for a patentability dispute
Federal Circuit’s mixed ruling: what affirmed, reversed, and remanded means for both sides
A split Federal Circuit disposition is rare — and consequential
When the Federal Circuit affirms-in-part, vacates-in-part, and reverses-in-part, it signals the lower tribunal’s patentability analysis was correct on some claims, legally flawed on others, and factually inadequate on still others. The remanded portion is returned to the lower forum for further fact-finding or legal analysis consistent with the Federal Circuit’s guidance. No single party achieves a clean win.
Three-way appellate dispositionOsteoMed retains partial protection — but remand creates ongoing exposure
The affirmed portion of the ruling preserves OsteoMed’s patent claims to the extent the lower tribunal upheld them, reinforcing enforceability for those specific claims. However, the reversal and vacatur expose OsteoMed to the risk that further proceedings could invalidate additional claims. Until remand is resolved, the commercial scope of US8529608B2 remains uncertain — complicating licensing strategy and enforcement decisions.
Partial patent survivalStryker and Wright Medical secure partial reversal — litigation continues
The appellants achieved a meaningful but incomplete result. The reversal-in-part suggests the Federal Circuit found at least some lower-level patentability determinations legally unsound in Stryker and Wright Medical’s favour. The vacatur-and-remand provides further opportunity to press validity arguments. However, the affirmed portion means not all challenges succeeded — appellants face continued proceedings before the case reaches final resolution.
Partial reversal securedOrthopaedic fixation sector faces prolonged IP uncertainty on bone plate design
A split Federal Circuit ruling on a bone plate patent with transfixation screw hole claims creates a zone of legal ambiguity that is likely to affect product design decisions, freedom-to-operate assessments, and competitive positioning for any company operating in orthopaedic fixation. Competitors should monitor the remand proceedings closely, as the final scope of enforceable claims will not be known until those proceedings conclude.
IP uncertainty persistsFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Stryker Corporation | Company | Orthopaedic device companies — challengers to US8529608B2 bone plate patent validitySearch in Eureka ↗ |
| Co-Plaintiff | Wright Medical Technology, Inc. | Company | Search in Eureka ↗ |
| Defendant | OsteoMed, LLC | Company | OsteoMed, LLC — orthopaedic implant company, holder of US8529608B2 bone plate patentSearch in Eureka ↗ |
| Plaintiff counsel | Robert Anthony Surrette | Attorney | Counsel for Stryker CorporationSearch in Eureka ↗ |
| Plaintiff counsel | Scott P. Mcbride | Attorney | Counsel for Stryker CorporationSearch in Eureka ↗ |
| Plaintiff counsel | Sean Sparrow I | Attorney | Counsel for Stryker CorporationSearch in Eureka ↗ |
| Plaintiff counsel | Sharon Hwang | Attorney | Counsel for Stryker CorporationSearch in Eureka ↗ |
| Plaintiff law firm | McAndrews, Held & Malloy Ltd. | Law Firm | Representing Stryker CorporationSearch in Eureka ↗ |
| Defendant counsel | Devon C. Beane | Attorney | Counsel for OsteoMed, LLCSearch in Eureka ↗ |
| Defendant counsel | Jason Alexander Engel | Attorney | Counsel for OsteoMed, LLCSearch in Eureka ↗ |
| Defendant law firm | Alston & Bird LLP | Law Firm | Representing OsteoMed, LLCSearch in Eureka ↗ |
| Defendant law firm | K&L Gates LLP | Law Firm | Representing OsteoMed, LLCSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s disposition — affirmed-in-part, vacated and remanded-in-part, reversed-in-part — reflects a granular, claim-by-claim review of the underlying patentability determination. At the appellate level, the court applies a de novo standard to legal questions of patentability while reviewing fact-findings for clear error. The reversal indicates the court found legal error in at least one lower determination; the vacatur signals inadequate record support requiring fresh analysis; the affirmance confirms some findings survived scrutiny. Partial dismissal of the appeal means certain issues were disposed of on procedural grounds without reaching the merits.
US8529608B2 — Bone plate with transfixation screw hole
US8529608B2, filed under application number US12/431017, protects a bone plate incorporating a transfixation screw hole — a structural feature enabling a screw to pass through and lock across a bone plate in orthopaedic fixation procedures. This design is relevant to surgical applications in extremity fracture repair and corrective osteotomy. The patent’s technical scope centres on the geometric and mechanical relationship between the plate structure and the screw channel, which distinguishes it from prior fixation plate designs and governs how surgeons achieve stable bone fixation intraoperatively.
For orthopaedic implant manufacturers, bone plate patents with specific screw hole geometries represent core IP assets because they directly govern product differentiation and surgical adoption. OsteoMed’s assertion of US8529608B2 against Stryker and Wright Medical — two of the largest names in orthopaedic devices — suggests this patent was viewed as competitively significant. Companies developing or selling bone fixation plates with transfixation features should treat this patent as an active monitoring priority until the Federal Circuit remand proceedings are fully resolved and final claim scope is established.
Should you run an FTO analysis against US8529608B2?
Any company designing, manufacturing, or distributing bone fixation plates with transfixation screw hole features should treat US8529608B2 as a live freedom-to-operate consideration. The Federal Circuit’s mixed ruling means the enforceable claim scope is not yet fully determined — the vacated-and-remanded portion could emerge from further proceedings with narrowed, broadened, or unchanged claims. Product teams should not treat the partial reversal as a clearance signal until final claim scope is confirmed.
PatSnap Eureka’s FTO Search Agent can map the current claim landscape of US8529608B2 against your product specifications, flag the specific claim elements at issue in the Federal Circuit proceedings, and generate a structured freedom-to-operate report. As the remand unfolds, Eureka’s monitoring tools can alert your team to any updated determinations — ensuring your FTO analysis stays current with the evolving legal status of this patent.
Run a freedom-to-operate analysis on US8529608B2 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit patentability appeals in orthopaedic device IP
Explore comparable Federal Circuit patentability appeals involving orthopaedic implant and bone fixation device patents with similarly contested claim validity outcomes.
What this case signals for the orthopaedic implant IP landscape
A split Federal Circuit ruling on a bone plate patent sends a clear signal: claim-by-claim validity analysis matters, and partial victories are real outcomes in complex medical device disputes.
Mixed Federal Circuit dispositions leave room for continued challenge
When a Federal Circuit panel splits its ruling across affirm, vacate, and reverse tracks, it typically signals that the original patentability record was uneven. Companies monitoring this patent should track the remand proceedings — the final scope of US8529608B2’s enforceable claims depends on what the lower tribunal determines on the vacated issues.
Orthopaedic fixation IP is actively contested at the highest appellate level
Stryker and Wright Medical’s willingness to sustain an 865-day Federal Circuit appeal over bone plate technology underscores the commercial value placed on orthopaedic fixation device IP. For in-house teams at competing device companies, this case reinforces that freedom-to-operate assessments on transfixation screw hole designs remain a live risk management issue.
Stryker v OsteoMed — key questions answered
The Federal Circuit issued a mixed ruling: affirmed-in-part, vacated and remanded-in-part, and reversed-in-part. The appeal was also dismissed in part. This means some lower patentability determinations on US8529608B2 were upheld, some were sent back for further proceedings, and some were overturned. No single party achieved a complete victory.
The patent at issue is US8529608B2, filed under application number US12/431017. It covers a bone plate with a transfixation screw hole — an orthopaedic surgical fixation device. The dispute concerns the patent’s validity and patentability, not infringement per se, as the verdict cause is listed as patentability/invalidity.
Vacatur of a portion of the lower ruling means those determinations have been nullified and sent back for further proceedings consistent with the Federal Circuit’s guidance. For US8529608B2, this means the enforceability of the vacated claims is not yet final. The patent retains some enforceable claims (the affirmed portion) but others remain subject to further adjudication at the lower tribunal.
The appeal was filed on May 22, 2023, and closed on October 3, 2025 — a duration of 865 days. This timeline is consistent with a complex patentability appeal involving multiple contested claim sets, extensive briefing, and the Federal Circuit’s docket scheduling.
Stryker Corporation and Wright Medical Technology were represented by McAndrews, Held & Malloy Ltd., with attorneys including Robert Anthony Surrette, Scott P. McBride, Sean Sparrow I, and Sharon Hwang. OsteoMed, LLC was represented by Alston & Bird LLP and K&L Gates LLP, with Devon C. Beane and Jason Alexander Engel appearing as counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.